ABGABEVORRICHTUNG

European patent · EP3870263 · In force

Register entry

Publication number
EP3870263
Application number
EP19876598
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 18, 2019
Published
Sep 1, 2021
Granted
Jan 7, 2026
Protection ends at the latest
Oct 17, 2039
Next annual fee due
Oct 31, 2026
IPC classes
A61M 36/06 (2006.01)
A61M 5/14 (2006.01)
A61N 5/10 (2006.01)
Priority
US 201862749322 P 23.10.2018
US 201862754355 P 01.11.2018
PCT application
PCT/CA2019/051478 18.10.2019
PCT publication
WO2020/082168 30.04.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 7, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 07.01.2026

Parties

Holder

ABK Biomedical Incorporated

Unit 32 - 155 Chain Lake Dr., Halifax, Nova Scotia B3S 1B3, CA

Inventor

HODGSON, David Mark Douglas

Halifax, Nova Scotia B3M 4Y4, CA

GREGOIRE, Marc Andre

Ottawa, Ontario K1S 0M4, CA

ATWELL, Kathryn Margaret Ann

Halifax, Nova Scotia B3L 2T4, CA

DONOFRIO, Gary Michael

Weddington, NC 28104, US

ABRAHAM, Robert Joseph

Hammonds Plains, Nova Scotia B4B 1L2, CA

WIENS, Evan Christopher

Halifax, Nova Scotia B3N 1X1, CA

KETTLEWELL, Brenna Catherine

Quispamsis, New Brunswick E2E 5Z9, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.